G. Yavuz Et Al. , "THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT," PEDIATRIC BLOOD & CANCER , vol.60, pp.86-87, 2013
Yavuz, G. Et Al. 2013. THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT. PEDIATRIC BLOOD & CANCER , vol.60 , 86-87.
Yavuz, G., DİNÇASLAN, H., TAÇYILDIZ, N., ÜNAL, E., Tanyildiz, G., YILDIZ, Y., ... Saglik, Y.(2013). THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT. PEDIATRIC BLOOD & CANCER , vol.60, 86-87.
Yavuz, G. Et Al. "THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT," PEDIATRIC BLOOD & CANCER , vol.60, 86-87, 2013
Yavuz, G. Et Al. "THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT." PEDIATRIC BLOOD & CANCER , vol.60, pp.86-87, 2013
Yavuz, G. Et Al. (2013) . "THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT." PEDIATRIC BLOOD & CANCER , vol.60, pp.86-87.
@article{article, author={G. Yavuz Et Al. }, title={THE COMBINED USE OF SORAFENIB AND BEVACIZUMAB WITH TRADITIONAL CHEMOTHERAPY PROTOCOL; PROMISING ANTITUMORAL ACTIVITY IN PATIENTS WITH PEDIATRIC UNRESECTABLE HIGH-GRADE AND METASTATIC OSTEOSARCOMA: PRELIMINARY REPORT}, journal={PEDIATRIC BLOOD & CANCER}, year=2013, pages={86-87} }